In our animal experiments, we employed a murine lung cancer cell line, LLC, and a murine hepatoma cell line, ML-1, both expressing substantial amounts of ENO1 on the surface (Figure 3A) [15]. The gene discussed is ENO1; the disease is hepatocellular carcinoma.